Faure F - Search Results

1

Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming.

Wolfers J, Lozier A, Raposo G, Regnault A, Théry C, Masurier C, Flament C, Pouzieux S, Faure F, Tursz T, Angevin E, Amigorena S, Zitvogel L. Wolfers J, et al. Among authors: faure f. Nat Med. 2001 Mar;7(3):297-303. doi: 10.1038/85438. Nat Med. 2001. PMID: 11231627

2

TCR activation of human T cells induces the production of exosomes bearing the TCR/CD3/zeta complex.

Blanchard N, Lankar D, Faure F, Regnault A, Dumont C, Raposo G, Hivroz C. Blanchard N, et al. Among authors: faure f. J Immunol. 2002 Apr 1;168(7):3235-41. doi: 10.4049/jimmunol.168.7.3235. J Immunol. 2002. PMID: 11907077

3

Diversity of the cytotoxic melanoma-specific immune response: some CTL clones recognize autologous fresh tumor cells and not tumor cell lines.

Dufour E, Carcelain G, Gaudin C, Flament C, Avril MF, Faure F. Dufour E, et al. Among authors: faure f. J Immunol. 1997 Apr 15;158(8):3787-95. J Immunol. 1997. PMID: 9103444

4

Long-lasting cross-presentation of tumor antigen in human DC.

Faure F, Mantegazza A, Sadaka C, Sedlik C, Jotereau F, Amigorena S. Faure F, et al. Eur J Immunol. 2009 Feb;39(2):380-90. doi: 10.1002/eji.200838669. Eur J Immunol. 2009. PMID: 19130478 Free article.

5

Blood monocytes sample MelanA/MART1 antigen for long-lasting cross-presentation to CD8⁺ T cells after differentiation into dendritic cells.

Faure F, Jouve M, Lebhar-Peguillet I, Sadaka C, Sepulveda F, Lantz O, Berre S, Gaudin R, Sánchez-Ramón S, Amigorena S. Faure F, et al. Int J Cancer. 2018 Jan 1;142(1):133-144. doi: 10.1002/ijc.31037. Epub 2017 Sep 26. Int J Cancer. 2018. PMID: 28884480

6

Exosomes bearing HLA-G are released by melanoma cells.

Riteau B, Faure F, Menier C, Viel S, Carosella ED, Amigorena S, Rouas-Freiss N. Riteau B, et al. Among authors: faure f. Hum Immunol. 2003 Nov;64(11):1064-72. doi: 10.1016/j.humimm.2003.08.344. Hum Immunol. 2003. PMID: 14602237

7

NADPH oxidase controls phagosomal pH and antigen cross-presentation in human dendritic cells.

Mantegazza AR, Savina A, Vermeulen M, Pérez L, Geffner J, Hermine O, Rosenzweig SD, Faure F, Amigorena S. Mantegazza AR, et al. Among authors: faure f. Blood. 2008 Dec 1;112(12):4712-22. doi: 10.1182/blood-2008-01-134791. Epub 2008 Aug 5. Blood. 2008. PMID: 18682599 Free PMC article.

8

Shifting the Balance of Activating and Inhibitory Natural Killer Receptor Ligands on BRAF^V600E Melanoma Lines with Vemurafenib.

Frazao A, Colombo M, Fourmentraux-Neves E, Messaoudene M, Rusakiewicz S, Zitvogel L, Vivier E, Vély F, Faure F, Dréno B, Benlalam H, Bouquet F, Savina A, Pasmant E, Toubert A, Avril MF, Caignard A. Frazao A, et al. Among authors: faure f. Cancer Immunol Res. 2017 Jul;5(7):582-593. doi: 10.1158/2326-6066.CIR-16-0380. Epub 2017 Jun 2. Cancer Immunol Res. 2017. PMID: 28576831

9

Lymphocyte-activation gene 3/major histocompatibility complex class II interaction modulates the antigenic response of CD4+ T lymphocytes.

Huard B, Tournier M, Hercend T, Triebel F, Faure F. Huard B, et al. Among authors: faure f. Eur J Immunol. 1994 Dec;24(12):3216-21. doi: 10.1002/eji.1830241246. Eur J Immunol. 1994. PMID: 7805750

10

Tumor-specific immune response: current in vitro analyses may not reflect the in vivo immune status.

Faure F, Even J, Kourilsky P. Faure F, et al. Crit Rev Immunol. 1998;18(1-2):77-86. doi: 10.1615/critrevimmunol.v18.i1-2.90. Crit Rev Immunol. 1998. PMID: 9419450 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

202 results

Search Page